Schedule 13G ownership disclosure

NPS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 62936P103

Event date: 2015-01-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,140,007
Percent of class
2.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000072971-15-000440
Form type
SC 13G/A
Filer
NPS PHARMACEUTICALS INC
CIK
CIK 890465
Filed
Feb 17, 2015
Reporting period
Jan 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub